NIH Guide + NIH RePORTER

Open NIH NOFOs: Due Dates, Institutes & Funded Projects

Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 19, 2026Editorial standards

NIH has 369 open notices of funding opportunity. The NIH Guide spreads each one across its own page, participation and due-date notices, and NOSIs. Each page here puts them together, and adds how many projects NIH actually funded under that NOFO.

Open now

343

Accepting applications

Opening soon

26

Posted, open date ahead

Due in 30 days

45

Next due date by Nov 22, 2026

With funding history

305

Funded projects under it or its predecessor

Due in the next 30 days

35 more in the full list below, sorted by next due date.

All NIH NOFOs

Search by NOFO number, title words, institute, or activity code. Filters stay in the address bar, so a filtered list can be bookmarked or shared.

369 NOFOs open or opening soon

NIH notices of funding opportunity with due dates and funded projects
NOFONext due
PAR-27-078
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
PAR · NIA + 11 more · R15
Oct 25, 2026
PAR-25-352
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
PAR · NIMH + 1 more · U01
Oct 25, 2026
PAR-25-353
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
PAR · NIMH + 1 more · U19
Oct 25, 2026
PAR-25-298
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
PAR · NIDCR + 18 more · R15
Oct 25, 2026
PAR-25-134
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
PAR · NIGMS + 21 more · R15
Oct 25, 2026
PAR-25-148
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
PAR · NICHD + 10 more · R15
Oct 25, 2026
PAR-25-103
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
PAR · NCI + 1 more · U34
Oct 25, 2026
PAR-25-104
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
PAR · NCI + 1 more · R34
Oct 25, 2026
RFA-AT-25-003
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
RFA · NCCIH + 6 more · R15
Oct 27, 2026
PAR-27-045
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
PAR · NCCIH + 6 more · R61, R33
Oct 30, 2026
RFA-HG-27-011
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
RFA · NHGRI + 1 more · U01
Oct 30, 2026
RFA-HG-27-012
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
RFA · NHGRI + 1 more · U01
Oct 30, 2026
RFA-HG-27-013
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
RFA · NHGRI + 1 more · U01
Oct 30, 2026
PAR-27-053
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
PAR · NIDA + 1 more · R61, R33
Nov 2, 2026
PAR-24-279
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
PAR · NIAMS + 1 more · R61
Nov 2, 2026
PAR-24-280
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
PAR · NIAMS + 1 more · R01
Nov 2, 2026
PAR-25-141
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
PAR · NIAMS + 1 more · UG3, UH3
Nov 2, 2026
PAR-25-437
Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed)
PAR · ECHO + 1 more · X01
Nov 4, 2026
PAR-25-149
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
PAR · NINDS + 1 more · U01
Nov 5, 2026
PAR-27-076
Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)
PAR · NIH + 15 more · SI2, R00
Nov 6, 2026
RFA-DK-27-125
Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
RFA · NIDDK + 1 more · U01
Nov 6, 2026
RFA-HL-27-010
Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
RFA · NHLBI + 2 more · K38
Nov 9, 2026
RFA-MH-27-125
Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)
RFA · NIMH + 2 more · R21, R33
Nov 9, 2026
RFA-AI-27-014
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)
RFA · NIAID + 5 more · U01
Nov 9, 2026
PAR-27-065
NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)
PAR · NINDS + 1 more · UG3, UH3
Nov 9, 2026
RFA-DK-27-112
Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
RFA · NIDDK + 1 more · U01
Nov 9, 2026
RFA-DK-27-139
Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
RFA · NIDDK + 1 more · U01
Nov 9, 2026
PAR-25-062
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
PAR · NIDCR + 1 more · UH3
Nov 9, 2026
RFA-RM-27-024
Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
RFA · RMOD + 3 more · R03
Nov 10, 2026
RFA-AI-27-018
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
RFA · NIAID + 17 more · R61, R33
Nov 10, 2026
RFA-OD-27-009
Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
RFA · OD + 4 more · SB0
Nov 10, 2026
PAR-27-096
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
PAR · NIA + 3 more · R03
Nov 10, 2026
PAR-27-112
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)
PAR · NIA + 1 more · K76
Nov 10, 2026
RFA-AG-27-010
Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
RFA · NIA + 1 more · U24
Nov 10, 2026
RFA-AI-27-002
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
RFA · NIAID + 1 more · UM1
Nov 10, 2026
RFA-AI-27-005
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
RFA · NIAID + 1 more · UM1
Nov 10, 2026
RFA-CA-27-001
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
RFA · NCI + 1 more · R61
Nov 10, 2026
RFA-CA-27-002
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
RFA · NCI + 1 more · R33
Nov 10, 2026
RFA-NS-26-001
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
RFA · NINDS + 2 more · U01
Nov 10, 2026
PAR-25-311
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
PAR · NICHD + 1 more · UG3, UH3
Nov 13, 2026
PAR-25-336
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
PAR · NCI + 1 more · R01
Nov 16, 2026
RFA-DK-27-122
Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
RFA · NIDDK + 1 more · U01
Nov 17, 2026
PAR-27-003
Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)
PAR · NIGMS + 12 more · RM1
Nov 17, 2026
RFA-DA-26-034
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
RFA · NIDA + 2 more · R01
Nov 18, 2026
PA-27-061
NIH Research Program Projects (Parent P01 Clinical Trial Optional)
PA · OD + 11 more · P01
Nov 20, 2026
RFA-RM-27-007
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
RFA · RMOD + 3 more · UG3, UH3
Nov 23, 2026
RFA-RM-27-016
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
RFA · RMOD + 3 more · UM1
Nov 23, 2026
RFA-RM-27-025
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
RFA · RMOD + 3 more · UM1
Nov 23, 2026
RFA-OD-27-008
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
RFA · OD + 5 more · Opens soon · F32
Dec 2, 2026
RFA-DA-26-055
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
RFA · NIDA + 1 more · R01
Dec 3, 2026

* Funded projects under the NOFO it reissues; the new number has no awards yet.

NIH NOFO questions

What is an NIH NOFO?

A Notice of Funding Opportunity (NOFO, formerly FOA) is the announcement NIH publishes in the NIH Guide for Grants and Contracts to invite applications. It sets the activity code, participating institutes, eligibility, budget, due dates, and review criteria. Every NIH grant application is submitted under a NOFO number such as PA-25-301.

What is the difference between a PA, PAR, and RFA?

A PA (Program Announcement) is an ongoing invitation, usually with standard due dates; parent announcements such as the parent R01 are PAs. A PAR is a program announcement with special receipt, referral, or review, often with its own due dates and a dedicated review panel. An RFA (Request for Applications) is a one-time solicitation with set-aside funds and usually a single due date.

Why does one NOFO have so many notices?

After posting, NIH changes a NOFO through separate notices in the NIH Guide: another institute joining (a participation notice), due-date changes, early expiration, or policy updates. Notices of Special Interest (NOSIs) are attached separately to signal topics an institute wants to fund through it. Each GotGrant NOFO page lists the related notices and active NOSIs together.

How are funded projects counted?

Funded projects come from NIH RePORTER, which records the NOFO number every award was made under. GotGrant counts distinct projects and award dollars for FY2022–FY2026. A new NOFO that reissues an older one shows the older NOFO's funding until awards appear under the new number.

How current is this list?

The NOFO list, notices, and NOSIs are refreshed from the NIH Guide every week, most recently on October 19, 2026. Funding counts from NIH RePORTER are refreshed every four weeks, most recently on October 16, 2026. Open or expired status and next due dates are recalculated daily. NOFOs posted after a refresh appear at the next one, so always confirm details in the NIH Guide before applying.

New to NIH funding? Start with the NIH funding guide or how to find NIH funding opportunities.